Sign Up to like & get
recommendations!
0
Published in 2018 at "Haematologica"
DOI: 10.3324/haematol.2018.194399
Abstract: TP53 mutations are associated with significant poorer outcomes in mantle cell lymphoma (MCL), and new treatment strategies are highly warranted. Lenalidomide has shown high efficacy in MCL; however, there is no knowledge of its effect…
read more here.
Keywords:
plus bendamustine;
lenalidomide plus;
mantle cell;
tp53 ... See more keywords